UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in TGTX — Tg Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in TGTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$7,822,542
+$707,316 QoQ
Shares Held
235,477
-1.3% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,605,811 across 211 Biotechnology names. TGTX ranks #51 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in TGTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,822,542 | 235,477 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,115,226 | 238,686 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,852,464 | 245,051 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,734,050 | 409,393 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,318,732 | 287,059 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $8,198,333 | 272,370 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,874,950 | 293,927 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,726,134 | 321,874 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,462,908 | 161,927 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,765,711 | 161,927 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,353,707 | 161,927 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,331,589 | 134,122 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,017,193 | 134,122 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,845,158 | 155,973 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $838,145 | 141,579 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $624,974 | 147,053 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,387,327 | 145,881 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,206,736 | 116,144 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,962,912 | 119,078 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,357,783 | 112,343 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,983,252 | 103,387 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $29,686,615 | 570,677 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $17,204,885 | 642,933 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $13,183,127 | 676,752 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $6,516,008 | 662,196 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||